Four World Capital Management LLC Evolus, Inc. Transaction History

Four World Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$9.99 - $14.91 $499,500 - $745,500	-50,000 Reduced 24.56%	153,620 $2.15 Million
Q4 2023 Feb 14, 2024	SELL	$7.6 - $10.53 $318,972 - $441,944	-41,970 Reduced 17.09%	203,620 $2.14 Million
Q4 2022 Feb 14, 2023	BUY	$6.52 - $8.95 $1.6 Million - $2.2 Million	245,590 New	245,590 $1.84 Million
Q3 2022 Nov 14, 2022	BUY	$7.76 - $13.72 $1.91 Million - $3.37 Million	245,590 New	245,590 $1.98 Million
Q1 2022 May 16, 2022	BUY	$5.22 - $11.78 $1.25 Million - $2.81 Million	238,690 New	238,690 $2.68 Million

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $561M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Four World Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Four World Capital Management LLC with notifications on news.